October 17, 2024
Mad Hedge Biotech and Healthcare Letter October 17, 2024 Fiat Lux Featured Trade: (NO TEARS HERE) (JNJ)
Entries by april@madhedgefundtrader.com
No Tears Here
If you've been following my adventures in the market jungle for any length of time, you know I've got a nose for opportunity that'd make a bloodhound jealous. Well, folks, that nose is twitching something fierce, and it's pointed straight at Johnson & Johnson (JNJ). Now, I know what you're thinking: "John, J&J? Aren't they
October 17, 2024
Global Market Comments October 17, 2024 Fiat Lux Featured Trade: (FRIDAY OCTOBER 25 SALT LAKE CITY UTAH STRATEGY LUNCHEON) (THIS IS NOT YOUR FATHER’S NUCLEAR POWER PLANT) (SMR), (MSFT), (GOOGL), (AMZN)
This is Not Your Father’s Nuclear Power Plant.
A 35% move-up in one day certainly gets one’s attention. The move was prompted by Microsoft’s (MSFT), Google (GOOGL), and Amazon’s (AMZN) move into the nuclear industry to supply electricity for AI data centers over the past two weeks. Building on my early career at the Atomic Energy Commission in the 1970’s, I have been
October 16, 2024
Mad Hedge Technology Letter October 16, 2024 Fiat Lux Featured Trade: (THE CHIP TRADE IS STILL IN-TACT) (ASML)
The Chip Trade Is Still In-Tact
Computer chip equipment maker ASML said they will cut 2025 financial guidance, citing weakness in markets other than AI and delayed orders. This triggered a steep sell-off in many chip names, and I view this as a healthy event. We are bombarded with so much robust news from the chip sector that it is hard
October 16, 2024
(A DISRUPTIVE MODEL COULD CHALLENGE THE BANKS) October 16, 2024 Hello everyone The big banks are in control, and nothing could shift their dominance, right? Well, it might be time for a re-think of that notion. In banking, the most potent disruptive model is coming from a group called ‘Revolut’ and it
Trade Alert - (GLD) October 15, 2024 - BUY
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
October 15, 2024
Mad Hedge Biotech and Healthcare Letter October 15, 2024 Fiat Lux Featured Trade: (THE BRIGHT SIDE OF A DARK DIAGNOSIS) (ILMN), (TMO), (A), (QGEN), (GH), (PFE)
The Bright Side Of A Dark Diagnosis
Let's face it. Cancer is still kicking our collective butts. Despite all the fancy lab coats and high-tech gadgets, cancer remains the second-leading cause of death in the U.S. It's like that annoying party guest who just won't leave, no matter how many hints you drop. This year alone, more than 2 million Americans are